These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 17079309

  • 21. MHC-restricted protection of cats against FIV infection by adoptive transfer of immune cells from FIV-vaccinated donors.
    Pu R, Omori M, Okada S, Rine SL, Lewis BA, Lipton E, Yamamoto JK.
    Cell Immunol; 1999 Nov 25; 198(1):30-43. PubMed ID: 10612649
    [Abstract] [Full Text] [Related]

  • 22. DNA vaccination using expression vectors carrying FIV structural genes induces immune response against feline immunodeficiency virus.
    Cuisinier AM, Mallet V, Meyer A, Caldora C, Aubert A.
    Vaccine; 1997 Jul 25; 15(10):1085-94. PubMed ID: 9269051
    [Abstract] [Full Text] [Related]

  • 23. Mechanism(s) of FIV vaccine protection.
    Pu R, Tellier MC, Yamamoto JK.
    Leukemia; 1997 Apr 25; 11 Suppl 3():98-101. PubMed ID: 9209311
    [Abstract] [Full Text] [Related]

  • 24. Vaccination with inactivated virus but not viral DNA reduces virus load following challenge with a heterologous and virulent isolate of feline immunodeficiency virus.
    Hosie MJ, Dunsford T, Klein D, Willett BJ, Cannon C, Osborne R, Macdonald J, Spibey N, Mackay N, Jarrett O, Neil JC.
    J Virol; 2000 Oct 25; 74(20):9403-11. PubMed ID: 11000209
    [Abstract] [Full Text] [Related]

  • 25. Neutralising antibody response in domestic cats immunised with a commercial feline immunodeficiency virus (FIV) vaccine.
    Bęczkowski PM, Harris M, Techakriengkrai N, Beatty JA, Willett BJ, Hosie MJ.
    Vaccine; 2015 Feb 18; 33(8):977-84. PubMed ID: 25613718
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Immunogenicity of an anti-clade B feline immunodeficiency fixed-cell virus vaccine in field cats.
    Matteucci D, Poli A, Mazzetti P, Sozzi S, Bonci F, Isola P, Zaccaro L, Giannecchini S, Calandrella M, Pistello M, Specter S, Bendinelli M.
    J Virol; 2000 Dec 18; 74(23):10911-9. PubMed ID: 11069985
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: failure to protect and possible enhancement of challenge infection by four cell-based vaccines prepared with autologous lymphoblasts.
    Giannecchini S, Isola P, Sichi O, Matteucci D, Pistello M, Zaccaro L, Del Mauro D, Bendinelli M.
    J Virol; 2002 Jul 18; 76(14):6882-92. PubMed ID: 12072489
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Passive antibody protection of cats against feline immunodeficiency virus infection.
    Hohdatsu T, Pu R, Torres BA, Trujillo S, Gardner MB, Yamamoto JK.
    J Virol; 1993 Apr 18; 67(4):2344-8. PubMed ID: 8383246
    [Abstract] [Full Text] [Related]

  • 35. Cellular immune responses to feline immunodeficiency virus (FIV) induced by dual-subtype FIV vaccine.
    Omori M, Pu R, Tanabe T, Hou W, Coleman JK, Arai M, Yamamoto JK.
    Vaccine; 2004 Dec 02; 23(3):386-98. PubMed ID: 15530685
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Differentiation of feline immunodeficiency virus vaccination, infection, or vaccination and infection in cats.
    Levy JK, Crawford PC, Kusuhara H, Motokawa K, Gemma T, Watanabe R, Arai S, Bienzle D, Hohdatsu T.
    J Vet Intern Med; 2008 Dec 02; 22(2):330-4. PubMed ID: 18371028
    [Abstract] [Full Text] [Related]

  • 38. 16alpha-Bromo-epiandrosterone therapy modulates experimental feline immunodeficiency virus viremia: initial enhancement leading to long-term suppression.
    Pedersen NC, North TW, Rigg R, Reading C, Higgins J, Leutenegger C, Henderson GL.
    Vet Immunol Immunopathol; 2003 Aug 15; 94(3-4):133-48. PubMed ID: 12909410
    [Abstract] [Full Text] [Related]

  • 39. Determining the feline immunodeficiency virus (FIV) status of FIV-vaccinated cats using point-of-care antibody kits.
    Westman ME, Malik R, Hall E, Sheehy PA, Norris JM.
    Comp Immunol Microbiol Infect Dis; 2015 Oct 15; 42():43-52. PubMed ID: 26459979
    [Abstract] [Full Text] [Related]

  • 40. Salmonella typhimurium aroA recombinants and immune-stimulating complexes as vaccine candidates for feline immunodeficiency virus.
    Tijhaar EJ, Huisman W, Huisman RC, Siebelink KH, Karlas JA, de Ronde A, van Herwijnen R, Mooi FR, Osterhaus AD.
    J Gen Virol; 1997 Dec 15; 78 ( Pt 12)():3265-75. PubMed ID: 9400977
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.